Non-serotonergic potentiation by (-)-pindolol of DOI-induced forward locomotion in rats: Possible involvement of β-adrenoceptors?

Journal of Neural Transmission

Volumn 107, Issue 8-9, 2000, Pages 903-917

  Kaur, P ^a   Ahlenius, S ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

adrenoceptors; DOI; Locomotor activity; Pindolol; Rat; Serotonin receptors

Indexed keywords

2 DIPROPYLAMINO 5 FLUORO 8 HYDROXYTETRALIN; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ANPIRTOLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; ISAMOLTANE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PINDOLOL; RESERPINE; SEROTONIN 1B AGONIST; SEROTONIN 1B ANTAGONIST; SEROTONIN 2 AGONIST;

ADRENERGIC SYSTEM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; LOCOMOTION; MOTOR ACTIVITY; NEUROTRANSMISSION; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; RAT;

5-HYDROXYTRYPTOPHAN; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANIMAL; BETAXOLOL; BIOGENIC MONOAMINES; DIHYDROXYPHENYLALANINE; DRUG SYNERGISM; INDOPHENOL; MALE; MOTOR ACTIVITY; PINDOLOL; PIPERAZINES; PIPERIDINES; PROPANOLAMINES; PROSENCEPHALON; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, SEROTONIN; RESERPINE; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0033787327     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020070041     Document Type: Article

References (47)

1. Antagonism of reserpine-induced suppression of spontaneous motor activity by stimulation of 5-HT(1A) receptors in rats
2. Evidence for an involvement of 5-HT(1B) receptors in the inhibition of male rat ejaculatory behavior produced by 5-HTP
3. In vivo intrinsic efficacy of the 5-HT(1A) receptor antagonists NAD-299, WAY-100635 and (S)-(-)-UH-301 at rat brain monoamine receptors
4. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT(1A) antagonists
5. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist
6. Pharmacology of the novel 5-HT(1A) receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin, (S)-UH-301: Inhibition of (R)-8-OH-DPAT-induced effects
7. The influence of antidepressants on central monoaminergic systems
8. 1-adrenoceptor antagonist
9. Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: Electrophysiological studies in the rat brain
10. Desipramine-yohimbine combination treatment of depression. Implications for the β-adrenergic receptor hypothesis of antidepressant action
11. Evidence that RU 24969-induced locomotor activity in C57/B1/6 mice is specifically mediated by the 5-HT(1B) receptor
12. The effect of adrenergic drugs on serotonin metabolism in the nucleus raphe dorsalis of the rat, studies by in vivo voltammetry
13. Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT(1A) autoreceptor in vivo
14. Anpirtoline hydrochloride
15. Effect of salbutamol on the cerebral levels, uptake and turnover of serotonin
16. Photocell measurements of rat motor activity
17. A pharmacological profile of the selective silent 5-HT(1A) receptor antagonist, WAY-100635
18. The effect of a β-adrenergic agonist on behaviors mediated by 5-HT(1A) and 5-HT(1B) receptors
19. Interaction between a selective 5-HT(1A) receptor antagonist and an SSRI in vivo: Effects on 5-HT cell firing and extracellular 5-HT
20. A match between binding to β-adrenoceptors and stimulation of adenylyl cyclase parameters of (-)-isoproterenol and salbutamol on rat brain
21. Potentiation of the fluoxetine-induced increase in dialysate levels of serotonin (5-HT) in the frontal cortex of freely moving rats by combined blockade of 5-HT(1A) and 5-HT(1B) receptors with WAY 100,635 and GR 127,935
22. 2-adrenoceptor agonist salbutamol, a putative antidepressant drug
23. Reduced brain serotonergic activity after repeated treatment with β-adrenoceptor antagonists
24. Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT(1A) and 5-HT(1B) receptor agonists 8-OH-DPAT and anpirtoline, as evidence by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181
25. Evidence for specific involvement of 5-HT(1A) and 5-HT(2A/C) receptors in the expression of patterns of spontaneous motor activity of the rat
26. (-)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis
27. 8-Hydroxy-2-(di-n-propylamino)tetralin, 8-OH-DPAT, a potent and selective simplified ergot congener with central 5-HT receptor stimulating activity
28. Catecholamines, sympatheomimetic drugs, and adrenergic receptor antagonists
29. VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
30. 2-adrenoceptors as the mechanism whereby (-)-pindolol enhances DOI-induced hyperlocomotion in rats
31. Potentiation of DOI-induced forward locomotion in rats by (-)-pindolol treatment
32. 3H]-ICI-118,551 and blocking potency of ICI-118,551
33. Simultaneous determination of dopamine DOPAC and homovanillic acid. Direct injection of supernatants from brain tissue homogenates in a liquid chromatography-electrochemical detection system
34. The 5-HT(1B) receptors
35. 2-selective adrenoceptor antagonist and can be used to characterize β-adrenoceptor populations in tissues
36. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment
37. Tricyclics and tetracyclics
38. Clinical features of adrenergic agonists and antagonists
39. Inhibition of in vitro and ex vivo uptake of noradrenaline and 5-hydroxytryptamine by five antidepressants; correlation with reduction of spontaneous firing rate of central monoaminergic neurones
40. Biochemical and behavioural effects of isamoltane, a β-adrenoceptor antagonist with affinity for the 5-HT(1B) receptor in the rat brain
41. 2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxy-phenyl)-2-aminopropane (2,5-DMA)
42. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT(1A) and 5-HT(1B) receptor antagonists on extracellular 5-HT in the rat frontal cortex in vivo
43. Attenuated feed-back inhibition of brain serotonin synthesis following chronic administration of imipramine
44. D-16949 (anpirtoline): A novel serotonergic (5-HT(1B)) psychotherapeutic agent assessed by its discriminative effects in the rat
45. Stimulation of central serotonin turnover by β-adrenoceptor agonists
46. 1 receptor subtypes in the rat brain